Sarah C NabingerLilly Corporate Center Eli Lilly and Company关注立即认领分享关注立即认领分享基本信息浏览量:0职业迁徙个人简介暂无内容研究兴趣论文共 2 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancerShani Paluch-Shimon,Patrick Neven,Jens Huober,Irfan Cicin,Matthew P Goetz,Chikako Shimizu,Chiun-Sheng Huang, Hans Joachim Lueck,Jane Beith,Eriko Tokunaga, Jessica Reyes Contreras, Rosane Oliveira de Sant'Ana,Ther Adv Med Oncol(2023)引用1浏览0WOS引用10Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1Masakazu Toi,Frances Boyle,Young-Hyuck Im,Mattea Reinisch,David Molthrop,Zefei Jiang,Ran Wei,Francisco Sapunar, Brenda R Grimes,Sarah Cassidy Nabinger,Stephen R D JohnstonOncologist(2023)引用3浏览0WOS引用30作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn